Capillary leak is an abnormal increase in the permeability of small blood vessels, allowing fluid and plasma proteins to move from the bloodstream into surrounding tissues. It can produce edema while reducing the effective circulating blood volume, sometimes causing dangerously low blood pressure and organ dysfunction. Capillary leak occurs in several illnesses and treatment-related reactions; it is not synonymous with systemic capillary leak syndrome, a rare disorder characterized by episodes of widespread vascular leakage.
Mechanism
The vascular endothelium, the cellular lining of blood vessels, regulates the passage of water and dissolved substances between blood and tissues. Its barrier function depends on endothelial cells, their junctions, and the protective surface layer known as the glycocalyx.
During inflammation, chemical signals can alter endothelial junctions and increase permeability. More severe endothelial injury can further disrupt the barrier. Plasma proteins, including albumin, then escape into the tissue spaces, accompanied by fluid.
This leakage has two simultaneous effects:
- Tissue swelling: fluid accumulates outside blood vessels.
- Intravascular depletion: less fluid remains within the circulation, potentially reducing blood flow to organs.
The lymphatic system normally returns excess tissue fluid and proteins to the bloodstream, but widespread leakage can exceed its capacity. Capillary leak is therefore distinct from swelling caused primarily by increased pressure within otherwise relatively intact vessels, as can occur in heart failure, or by impaired lymphatic drainage.
Causes and clinical settings
Secondary capillary leak
Increased vascular permeability is an important component of sepsis and can also occur with severe burns, major tissue injury, and anaphylaxis. Its distribution and severity depend on the underlying process: leakage may predominantly affect one organ or become widespread.
Some anticancer treatments can cause capillary leak syndrome. Recognized examples include interleukin-2 and certain other immune or targeted therapies. Vascular leakage can also accompany cytokine release syndrome, including after CAR T-cell therapy. In these settings, capillary leak is part of a treatment-associated inflammatory response rather than necessarily a separate disease.
Idiopathic systemic capillary leak syndrome
Idiopathic systemic capillary leak syndrome, also called Clarkson disease, is a rare disorder first described in 1960. It causes recurrent episodes of increased vascular permeability without an established secondary cause.
Its characteristic clinical triad consists of:
- Hypotension: abnormally low blood pressure.
- Hemoconcentration: an increased concentration of blood cells as plasma leaves the circulation, commonly reflected by a raised hematocrit.
- Hypoalbuminemia: a reduced blood albumin concentration caused by protein leakage.
Many affected adults have an associated monoclonal gammopathy of undetermined significance. This association does not establish that the monoclonal protein directly causes vascular leakage, and its absence does not exclude the syndrome.
Clinical course and complications
Manifestations vary with the cause and extent of leakage. Generalized swelling, rapid weight gain from fluid accumulation, weakness, and reduced urine output may occur. Severe intravascular depletion can lead to shock.
In classic episodic systemic capillary leak syndrome, an attack may begin with nonspecific symptoms such as fatigue, muscle aches, or influenza-like symptoms. During the leak phase, fluid and proteins leave the circulation. During the subsequent recovery phase, barrier function improves and accumulated fluid returns to the bloodstream.
This reversal is clinically important: a person who was initially intravascularly depleted may subsequently develop circulatory fluid overload and pulmonary edema. Other complications include acute kidney injury, thrombosis, and compartment syndrome, in which swelling raises pressure within an enclosed muscle compartment and compromises tissue perfusion.
Diagnosis
The diagnosis of capillary leak depends on the clinical setting, changes in fluid distribution, laboratory findings, and evidence of an underlying cause. There is no single test that identifies every form of capillary leak.
Evaluation may document low blood pressure, edema, falling albumin concentrations, and changes in blood-cell concentration. The classic triad of idiopathic systemic capillary leak syndrome is informative, but it is not present in every secondary form. Bleeding, anemia, and administered fluids can alter laboratory findings.
The differential diagnosis includes sepsis, anaphylaxis, heart failure, and disorders causing substantial protein loss through the kidneys or gastrointestinal tract. Idiopathic systemic capillary leak syndrome is diagnosed after alternative explanations have been assessed. A monoclonal protein can support the clinical context but is not independently diagnostic.
Management and evidence
Management addresses the underlying cause and the consequences of intravascular depletion and tissue edema. Severe episodes require hospital-based supportive care, with close assessment of circulation, organ function, and changing fluid balance. Fluid administration is complicated by the possibility that infused fluid will enter tissues during active leakage and later return to the circulation.
For recurrent idiopathic systemic capillary leak syndrome, intravenous immunoglobulin has been used as preventive treatment. Observational studies report reductions in attack frequency, but the rarity of the disorder limits the availability of large randomized controlled trials. Evidence from idiopathic disease cannot automatically be applied to capillary leak caused by infection, injury, or medication.